Innovation Ventures Search Results
Narrow Your Results
Filter
Technology PatentStatus
- All (6)
- Issued Patent (1)
- National Phase Entry (0)
- PCT Filing (1)
- Provisional Filing (1)
- US Non-Provisional Filing (3)
Technology Categories
- All (6)
- Diagnostics (3)
- Educational Tools and Consumer Products (0)
- Medical Devices (1)
- Other (0)
- Research Tools (0)
- Software (0)
- Therapeutics (2)
Technology Stage Of Development
- All Results (2)
- Cell and Gene Therapy (0)
- Organoids (0)
- Other Biologics and Macromolecules (1)
- Small Molecule (0)
- Vaccines (1)
Results (6)
Biomarker Response Signatures of Children Receiving Infliximab for Crohn’s Disease
Plasma Proteomic Response Signature of Children Receiving Infliximab for Crohn’s Disease
Elevated Oncostatin M Predicts Non-response to Anti-TNF Therapy
Oncostatin M biomarkers are associated with non-response to Infliximab therapy
Microbiota-derived retinoid boosts immunity
Probiotic bacteria strains increase infection resistance.
Non-Invasive Eosinophilic Gastritis Diagnostic
Non-Invasive Eosinophilic Gastritis Diagnostic
Recombinant Polyvalent Complexes for Enhanced Immunogenicity in Vaccine Development
This technology offers a method of preparing very large protein complexes for use as multivalent vaccines against infections of multiple types.
Spherical implant to improve surgical outcomes for patients with esophageal Atresia
Spheric endo-luminal traction device helps improve surgical outcomes for individuals with long-gap esophageal atresia
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026
© 1999-2025 Cincinnati Children's Hospital Medical Center. All rights reserved.
